CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹25,774 Cr | ₹22,753 Cr | ₹21,763 Cr | ₹19,160 Cr | ₹17,132 Cr |
What is the latest Revenue of CIPLA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹25,774 Cr |
| Mar2024 | ₹22,753 Cr |
| Mar2023 | ₹21,763 Cr |
| Mar2022 | ₹19,160 Cr |
| Mar2021 | ₹17,132 Cr |
How is Revenue of CIPLA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹25,774 Cr | 13.28 | |
| Mar2024 | ₹22,753 Cr | 4.55 | |
| Mar2023 | ₹21,763 Cr | 13.59 | |
| Mar2022 | ₹19,160 Cr | 11.84 | |
| Mar2021 | ₹17,132 Cr | - | |
Compare Revenue of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹121,755.7 Cr | 1.1% | -1.6% | 4.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,220.0 Cr | 1.2% | 2.3% | -1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,486.0 Cr | 0.9% | -2.5% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,963.0 Cr | 0.5% | -1.5% | 12.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,866.0 Cr | 2.7% | 2.9% | 3.3% | Stock Analytics | |
| MANKIND PHARMA | ₹88,460.0 Cr | -1.7% | -5.5% | -16.9% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.1% |
-1.6% |
4.3% |
| SENSEX | 0.1% |
0.9% |
4.5% |
You may also like the below Video Courses